Menopause Information
Sleep Apnea and People Who are at Risk
It is estimated that almost 12 million people in the United States suffer with sleep apnea . Almost half of them have one other thing in common: they are over weight. Due to these findings researchers could not help but link the sleep disorder with obesity or an excessive weight…
Jury rules for Pfizer in Prempro case
A Wyeth menopause drug did not cause a woman’s breast cancer, and the drugmaker is not liable for damages, a Philadelphia jury found yesterday–two days after another local jury found against parent company Pfizer and levied nearly $10 million in damages. Report
Original Source of Jury rules for Pfizer in…
Summit is on, but it’s tomorrow that counts
The big bipartisan healthcare-reform summit is taking place as we speak, but Democrats and President Obama have already started looking past that meeting. Lawmakers are talking post-meeting strategy, and Obama has readied a fallback plan should his comprehensive proposal floated earlier this week prove unsellable. That “Plan B” would extend…
Pharma gets by with help from your friends
When you’re feeling weird and you’re health’s no good, who’re you gonna call? Big Pharma? For increasing numbers of patients, the answer to that question is “my friends.” So Big Pharma is taking advantage of that fact, tailoring advertising and Internet action so that prospective consumers hear from real people…
GSK aims to take down Senate report
GlaxoSmithKline has come out swinging in self-defense. The drugmaker issued a 30-page statement that vociferously denies that it conceals any safety information on the embattled drug Avandia or that it disregarded the needs of patients. And it stepped up its backing for the diabetes med, saying that a recent Senate…
Philly jury awards $9.45M in Prempro case
Pfizer’s Wyeth unit was ordered to pay $6 million in punitive damages to an Alabama woman who developed breast cancer after taking the company’s menopause drugs, bringing the total award in the case to $9.45 million. Report
Original Source of Philly jury awards $9.45M in Prempro case
Avastin fails stomach-cancer trial
Roche got a big disappointment today: The cancer drug Avastin failed a clinical trial in stomach cancer, one of the new indications the drugmaker had been aiming for. The company had predicted sales for stomach-cancer patients could have reached as high as 1 billion Swiss francs, or $933 million. Here’s…
Fewer med schools take pharma support
A new survey quantifies a trend we’ve seen: Fewer medical schools are accepting gifts and support from drug and device makers. According to the study published in the Archives of Internal Medicine , 56 percent of internal medicine program directors say they accepted free food and teaching materials. That’s down…

